Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MYL:US

59.3500 USD 0.6500 1.08%

As of 20:10:00 ET on 03/31/2015.

Snapshot for Mylan NV (MYL)

Open: 59.5600 Day's Range: 58.9000 - 60.4050 Volume: 8,447,303
Previous Close: 60.0000 52wk Range: 44.7400 - 65.6300 1-Yr Rtn: +20.36%

Stock Chart for MYL

No chart data available.
  • MYL:US 59.3300
  • 1D
  • 1M
  • 1Y
60.0000
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 19.7980
Estimated P/E(12/2015) 14.3254
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) 2.9978
Est. EPS (USD) (12/2015) 4.1430
Est. PEG Ratio 1.2813
Market Cap (M USD) 29,046.26
Shares Outstanding (M) 489.41
30 Day Average Volume 4,869,748
Price/Book (mrq) 6.8397
Price/Sale (ttm) 2.8736
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil